WeVote
Log In

Bill

Bill

HB 3212

Relating to pharmacy benefits.

2025 Regular Session Introduced by Court Boice and 24 co-sponsors

HB 3212 modifies Oregon pharmacy benefits management practices to address drug pricing, access, or transparency issues affecting patient medication costs.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · HB 3212

Legislative bill overview

HB 3212 addresses pharmacy benefits management practices in Oregon, though specific provisions aren't detailed in the available information. The bill has undergone committee review and a public hearing, indicating substantive policy changes to how pharmacy services or drug benefits are regulated in the state.

Why is this important

Pharmacy benefits management directly affects drug prices, patient access to medications, and healthcare costs for Oregon residents and insurers. Changes to these practices can influence transparency in pharmaceutical pricing and the affordability of prescription drugs across the state.

Potential points of contention

  • PBM transparency vs. business confidentiality – Regulations requiring disclosure of pricing practices may conflict with industry claims about proprietary business methods
  • Cost allocation – Determining who bears costs of regulatory compliance (insurers, pharmacies, patients, or PBMs) creates stakeholder disputes
  • Market competition concerns – Rules intended to lower costs could inadvertently reduce competition or market entry for smaller pharmacy operators

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.